PATRICIA HARREN: Open Payments
NPI 1164463444 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 30 payments from 7 companies in 2025. Trend: 2023 $1,628 · 2024 $59 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 17 | $683 |
| Gilead Sciences, Inc. | 4 | $89 |
| ABBVIE INC. | 3 | $68 |
| Ipsen Biopharmaceuticals, Inc | 2 | $67 |
| Intra-Sana Laboratories | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: REZDIFFRA, MAVYRET, IQIRVO, RELTONE 200 MG, TERLIVAZ, XIFAXAN.
Industry payments across NY — which companies pay providers there.
